A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*

<strong>UNASSIGNED : </strong>To determine the safety and efficacy of recombinant thrombomodulin (ART-123) in patients with suspected sepsis-associated disseminated intravascular coagulation.<br /><strong>UNASSIGNED : </strong>Phase 2b, international, multicenter, doubl...

Full description

Saved in:
Bibliographic Details
Main Authors: Vincent JL., Ramesh MK., Ernest D., Larosa SP., Pachl J., Aikawa N., Hoste E., Levy H., Hirman J., Levi M., Daga M., Kutsogiannis DJ., Crowther M., Bernard GR., Devriendt J., Puigserver JV., Blanzaco DU., Esmon CT., Parrillo JE., Guzzi L., Henderson SJ., Pothirat C., Mehta P., Fareed J., Talwar D., Tsuruta K., Gorelick KJ., Osawa Y., Kaul I.
Format: Article
Language:English
Published: 2014
Online Access:http://www.ncbi.nlm.nih.gov/pubmed/23979365
http://cmuir.cmu.ac.th/handle/6653943832/4188
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English

Internet

http://www.ncbi.nlm.nih.gov/pubmed/23979365
http://cmuir.cmu.ac.th/handle/6653943832/4188

Similar Items